Suzette Delaloge
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Suzette Delaloge
Oct 18, 2024, 12:10 |
Blog
From One-Size-Fits-All to Personalized Treatment: An article by Marleen Kok et al.
Maryam Lustberg shared on LinkedIn: "From One-Size-Fits-All to Personalized Treatment: Challenges and Potential Solutions. Opportunities…
Sep 25, 2024, 15:58 |
Blog
ESMO 2024: Precision Oncology and the Future of Molecular Prevention - MediaMedic
MediaMedic shared a post on LinkedIn about MediaMedic article, adding: "ESMO 2024: Precision Oncology and…
Aug 18, 2024, 07:29 |
Blog
,
Opinion
Paolo Tarantino: Do all patients with TNBC need 5 neoadjuvant drugs + 1 year of IO?
Paolo Tarantino shared a post on X about recent paper by Marleen Kok et al., titled…
Aug 5, 2024, 01:55 |
Societies
Scientific Committees at the ESMO Congress 2024
The ESMO Congress is a globally influential oncology platform that brings together clinicians, researchers, patient…
Jul 27, 2024, 22:17 |
Insight
Commentary led by Marleen Kok highlights all questions in early TNBC post-KN522
Erika Hamilton shared on X: "This commentary led by Marleen Kok highlights all the pertinent…
Jul 26, 2024, 00:03 |
Blog
Elisa Agostinetto: Must-read by Marleen Kok on the limitations of KEYNOTE-522
Elisa Agostinetto shared on X: "Out in JCO a must-read by Marleen Kok on the…
Jul 25, 2024, 08:58 |
Insight
Marleen Kok: How do we get from one-size-fits-all to personalized treatment for TNBC
Marleen Kok, Breast Medical Oncologist at the Netherlands Cancer Institute, shared on X: "Today from…
Jun 22, 2024, 00:42 |
Blog
Results from AMEERA-5 published in Journal of Clinical Oncology
Paolo Tarantino shared a post on X: "Results from AMEERA-5 published in Journal of Clinical Oncology.…
Jun 4, 2024, 14:12 |
Societies
Don't miss out to the chance to stay informed and deepen your knowledge on Breast Cancer - ESMO
The European Society for Medical Oncology (ESMO) recently shared a post on LinkedIn: "Make the…
May 21, 2024, 10:00 |
Blog
Erika Hamilton: Thanks to all who attended ESMO Breast24 and made it such a success
Erika Hamilton shared a post on LinkedIn: ''Thanks to all who attended ESMO Breast24 and…
May 18, 2024, 03:08 |
Blog
AI in Breast Cancer management is revolutionising the field - ESMO
ESMO shared a post on LinkedIn: "The rapid integration of Artificial Intelligence in Breast Cancer…
May 14, 2024, 16:52 |
Insight
Fabrice Andre: This risk-based approach is the foundation of modern cancer prevention centers
Fabrice Andre, Head of Research Division at Gustave Roussy, shared on X: "In this review of…
May 14, 2024, 10:25 |
Insight
Erman Akkus: Balance between overtreatment and undertreatment in DCIS
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: “Ductal carcinoma in…
Apr 17, 2024, 10:09 |
Positive
Yaniss B.: The 3rd edition of the Transatlantic Exchanges in Oncology was a huge success!
Yaniss B, Valorisation Officer at Gustave Roussy Transfert shared on X: “The 3rd edition of the…
All:
14
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube